Literature DB >> 20587492

The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease.

H J Cho1, Y H Jung, Y D Kim, H S Nam, D S Kim, J H Heo.   

Abstract

BACKGROUND AND
PURPOSE: The pattern of infarctions based on the findings of diffusion-weighted image was assessed, and it was also investigated whether there are any age-specific differences in patients with moyamoya disease (MMD).
METHODS: The subjects were 66 consecutive patients with MMD who had an acute cerebral infarction. Each ischaemic lesion was categorised into one of seven patterns (gyral, atypical territorial, honeycomb, classic territorial, multiple-dot, borderzone, deep lacunar) based on diffusion-weighted image findings. The patterns were compared between adulthood-onset MMD (A-MMD, ≥20 years old, 34 patients) and childhood/adolescent-onset MMD (C-MMD, <20 years old, 32 patients) according to their ages of infarct presentation.
RESULTS: A total of 91 infarct patterns were observed from 66 patients. The gyral, atypical territorial, and honeycomb patterns, which are not usually seen in conventional stroke patients, were common in MMD (68.1%). Among all patterns, a gyral pattern was most common (40/91, 44.0%). Borderzone and deep lacunar patterns were infrequent. Gyral and borderzone patterns were more frequently seen in the C-MMD group, whereas a honeycomb pattern was not seen in young patients. Honeycomb pattern was more common at advanced vascular stages. Infarctions confined to the cortex were more common in the C-MMD group (26/32, 75.0%) than in A-MMD patients (14/34, 41.2%).
CONCLUSIONS: Moyamoya disease showed various characteristic and age-specific infarct patterns. Different infarct patterns between the A-MMD and C-MMD groups may be associated with age-specific vulnerability of the brain to ischaemia, stage of arteriopathy or changes of abnormal collateral pathways.

Entities:  

Mesh:

Year:  2010        PMID: 20587492     DOI: 10.1136/jnnp.2009.181487

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

Review 1.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

2.  Revascularization for Posterior Cerebral Artery Infarction in Decompensated Moyamoya Disease.

Authors:  Gabe Sexton; Matthew Lommen; Caleb J Heiberger; Tej I Mehta; Douglas Yim
Journal:  Cureus       Date:  2019-09-17

3.  Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.

Authors:  Rolf R Diehl; Markus Kraemer; Mosche Pompsch; Roland Veltkamp
Journal:  J Neurol       Date:  2022-08-24       Impact factor: 6.682

4.  The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; In Bo Han; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

5.  Reversible diffusion weighted imaging hyperintensities during the acute phase of ischemic stroke in pediatric moyamoya disease: a case report.

Authors:  Goichiro Tamura; Satoshi Ihara; Nobuhito Morota
Journal:  Childs Nerv Syst       Date:  2016-03-14       Impact factor: 1.475

6.  Paediatric Stroke: Review of the Literature and Possible Treatment Options, including Endovascular Approach.

Authors:  Elisa F Ciceri; Valeria Cuccarini; Luisa Chiapparini; Veronica Saletti; Luca Valvassori
Journal:  Stroke Res Treat       Date:  2011-07-07

Review 7.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

Review 8.  Single Nucleotide Polymorphism in Patients with Moyamoya Disease.

Authors:  Young Seok Park
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 9.  Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis.

Authors:  Jong S Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

10.  Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study.

Authors:  Woo-Keun Seo; Jae-Young Kim; Eun-Hyeok Choi; Ye-Sel Kim; Jong-Won Chung; Jeffrey L Saver; Oh Young Bang; Gyeong-Moon Kim
Journal:  J Am Heart Assoc       Date:  2021-02-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.